☰

Kerry L. Burnstein

Affiliations: 
University of Miami, Coral Gables, FL 
Area:
Cell Biology, Pharmacology, Oncology
Google:
"Kerry Burnstein"
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Selena K. Krajewski grad student 2003 University of Miami
Eddy S. Yang grad student 2003 University of Miami
Zhengying Wang grad student 2009 University of Miami
Omar Flores grad student 2010 University of Miami
Shuyun Rao grad student 2010 University of Miami

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lyles RDZ, Martinez MJ, Sherman B, et al. (2023) Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens. Plos One. 18: e0287126
Martinez MJ, Lyles RDZ, Peinetti N, et al. (2023) Inhibition of the serine/threonine kinase BUB1 reverses taxane resistance in prostate cancer. Iscience. 26: 107681
Peinetti N, Bilusic M, Burnstein KL. (2022) Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy? The Journal of Clinical Investigation. 132
Heidman LM, Peinetti N, Copello VA, et al. (2022) Exploiting dependence of castration-resistant prostate cancer on the arginine vasopressin signaling axis by repurposing vaptans. Molecular Cancer Research : McR
Copello VA, Burnstein KL. (2022) The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor. Oncogene. 41: 2824-2832
Zhao N, Peacock SO, Lo CH, et al. (2019) Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer. Science Translational Medicine. 11
Arora* H, Panara K, Kuchakulla M, et al. (2019) MP81-04 ALTERATIONS OF TUMOR MICROENVIRONMENT BY NITRIC OXIDE DONOR IMPEDES CASTRATION RESISTANT PROSTATE CANCER GROWTH Journal of Urology. 201
Arora H, Panara K, Kuchakulla M, et al. (2018) Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth. Proceedings of the National Academy of Sciences of the United States of America
Birnbaum MD, Zhao N, Moorthy BT, et al. (2018) Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis. Oncogene
Magani F, Bray ER, Martinez MJ, et al. (2018) Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer. Molecular Systems Biology. 14: e8202
See more...